Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
VAT Womens Shorts Womens Shorts EUR 39.90 EUR 39.90 0.00 incl
Legal and regulatory status remains restrictive in many regions, where BPC-157 is not approved for clinical use and is typically limited to research contexts
At Refine by Tulsi, we often integrate NAD+ with: Peptide Therapy Synergistic protocols for energy, recovery, and cognitive function Hormone Optimization Especially for women experiencing perimenopause or menopause-related energy decline IV Vitamin Therapy Combine NAD+ with targeted micronutrients for enhanced cellular function Metabolic Support Including GLP-1 therapy for weight management and insulin sensitivity NAD+ in Refine Her Memberships Our Refine Her Thrive Tier includes monthly NAD+ IV or at-home injection kits as part of comprehensive womens wellness care
This product is neither a drug, food, nor cosmetic, and must not be misrepresented, misused, or mislabeled as such
BPC-157 is used in cell-based assay research examining its interactions with growth factor receptor signalling pathways, including FAK-paxillin pathway activation and downstream phosphorylation events
For systemic or musculoskeletal targets, injectable has a pharmacokinetic advantage
